Derek Meisner - Sep 6, 2022 Form 4 Insider Report for Acumen Pharmaceuticals, Inc. (ABOS)

Role
Chief Legal Office & Corp Sec
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
ABOS
Transactions as of
Sep 6, 2022
Transactions value $
$0
Form type
4
Date filed
9/7/2022, 04:31 PM
Previous filing
Aug 19, 2022
Next filing
Jan 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABOS Employee Stock Option (right to buy) Award $0 +225K $0.00 225K Sep 6, 2022 Common Stock 225K $6.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on September 6, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest and become exercisable each month thereafter, subject to Reporting Person continuing to provide service through each such date.